Supplementary Figure Legend from Prognostic Significance of AKT/mTOR and MAPK Pathways and Antitumor Effect of mTOR Inhibitor in NF1-Related and Sporadic Malignant Peripheral Nerve Sheath Tumors Article Swipe

PDF

Makoto Endo , Hidetaka Yamamoto , Nokitaka Setsu , Kenichi Kohashi , Yusuke Takahashi , Takeaki Ishii , Kei-ichiro Iida , Yoshihiro Matsumoto , Michiyuki Hakozaki , Mikiko Aoki , Hiroshi Iwasaki , Yoh Dobashi , Kenichi Nishiyama , Yukihide Iwamoto , Yoshinao Oda ·

YOU? · · 2023 · Open Access · · DOI: https://doi.org/10.1158/1078-0432.22455300.v1

PDF file - 72K

Related Topics

Concepts

PI3K/AKT/mTOR pathway Protein kinase B Medicine MAPK/ERK pathway Peripheral Cancer research Discovery and development of mTOR inhibitors Internal medicine Signal transduction Biology Cell biology

Metadata

Type: preprint
Language: en
Landing Page: https://doi.org/10.1158/1078-0432.22455300.v1
PDF: https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_Legend_from_Prognostic_Significance_of_AKT_mTOR_and_MAPK_Pathways_and_Antitumor_Effect_of_mTOR_Inhibitor_in_NF1-Related_and_Sporadic_Malignant_Peripheral_Nerve_Sheath_Tumors/22455300/1/files/39906432.pdf
OA Status: gold
Related Works: 10
OpenAlex ID: https://openalex.org/W4361910373

All OpenAlex metadata

Raw OpenAlex JSON

OpenAlex ID: https://openalex.org/W4361910373

Canonical identifier for this work in OpenAlex
DOI: https://doi.org/10.1158/1078-0432.22455300.v1

Digital Object Identifier
Title: Supplementary Figure Legend from Prognostic Significance of AKT/mTOR and MAPK Pathways and Antitumor Effect of mTOR Inhibitor in NF1-Related and Sporadic Malignant Peripheral Nerve Sheath Tumors

Work title
Type: preprint

OpenAlex work type
Language: en

Primary language
Publication year: 2023

Year of publication
Publication date: 2023-03-31

Full publication date if available
Authors: Makoto Endo, Hidetaka Yamamoto, Nokitaka Setsu, Kenichi Kohashi, Yusuke Takahashi, Takeaki Ishii, Kei-ichiro Iida, Yoshihiro Matsumoto, Michiyuki Hakozaki, Mikiko Aoki, Hiroshi Iwasaki, Yoh Dobashi, Kenichi Nishiyama, Yukihide Iwamoto, Yoshinao Oda

List of authors in order
Landing page: https://doi.org/10.1158/1078-0432.22455300.v1

Publisher landing page
PDF URL: https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_Legend_from_Prognostic_Significance_of_AKT_mTOR_and_MAPK_Pathways_and_Antitumor_Effect_of_mTOR_Inhibitor_in_NF1-Related_and_Sporadic_Malignant_Peripheral_Nerve_Sheath_Tumors/22455300/1/files/39906432.pdf

Direct link to full text PDF
Open access: Yes

Whether a free full text is available
OA status: gold

Open access status per OpenAlex
OA URL: https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_Legend_from_Prognostic_Significance_of_AKT_mTOR_and_MAPK_Pathways_and_Antitumor_Effect_of_mTOR_Inhibitor_in_NF1-Related_and_Sporadic_Malignant_Peripheral_Nerve_Sheath_Tumors/22455300/1/files/39906432.pdf

Direct OA link when available
Concepts: PI3K/AKT/mTOR pathway, Protein kinase B, Medicine, MAPK/ERK pathway, Peripheral, Cancer research, Discovery and development of mTOR inhibitors, Internal medicine, Signal transduction, Biology, Cell biology

Top concepts (fields/topics) attached by OpenAlex
Cited by: 0

Total citation count in OpenAlex
Related works (count): 10

Other works algorithmically related by OpenAlex

Full payload

id	https://openalex.org/W4361910373
doi	https://doi.org/10.1158/1078-0432.22455300.v1
ids.doi	https://doi.org/10.1158/1078-0432.22455300.v1
ids.openalex	https://openalex.org/W4361910373
fwci
type	preprint
title	Supplementary Figure Legend from Prognostic Significance of AKT/mTOR and MAPK Pathways and Antitumor Effect of mTOR Inhibitor in NF1-Related and Sporadic Malignant Peripheral Nerve Sheath Tumors
biblio.issue
biblio.volume
biblio.last_page
biblio.first_page
topics[0].id	https://openalex.org/T11173
topics[0].field.id	https://openalex.org/fields/27
topics[0].field.display_name	Medicine
topics[0].score	0.9994000196456909
topics[0].domain.id	https://openalex.org/domains/4
topics[0].domain.display_name	Health Sciences
topics[0].subfield.id	https://openalex.org/subfields/2728
topics[0].subfield.display_name	Neurology
topics[0].display_name	Neurofibromatosis and Schwannoma Cases
topics[1].id	https://openalex.org/T12226
topics[1].field.id	https://openalex.org/fields/27
topics[1].field.display_name	Medicine
topics[1].score	0.9782999753952026
topics[1].domain.id	https://openalex.org/domains/4
topics[1].domain.display_name	Health Sciences
topics[1].subfield.id	https://openalex.org/subfields/2728
topics[1].subfield.display_name	Neurology
topics[1].display_name	Neuroblastoma Research and Treatments
topics[2].id	https://openalex.org/T10253
topics[2].field.id	https://openalex.org/fields/27
topics[2].field.display_name	Medicine
topics[2].score	0.9679999947547913
topics[2].domain.id	https://openalex.org/domains/4
topics[2].domain.display_name	Health Sciences
topics[2].subfield.id	https://openalex.org/subfields/2740
topics[2].subfield.display_name	Pulmonary and Respiratory Medicine
topics[2].display_name	Sarcoma Diagnosis and Treatment
is_xpac	False
apc_list
apc_paid
concepts[0].id	https://openalex.org/C86554907
concepts[0].level	3
concepts[0].score	0.8955535888671875
concepts[0].wikidata	https://www.wikidata.org/wiki/Q285613
concepts[0].display_name	PI3K/AKT/mTOR pathway
concepts[1].id	https://openalex.org/C75217442
concepts[1].level	3
concepts[1].score	0.757625937461853
concepts[1].wikidata	https://www.wikidata.org/wiki/Q423650
concepts[1].display_name	Protein kinase B
concepts[2].id	https://openalex.org/C71924100
concepts[2].level	0
concepts[2].score	0.6529040932655334
concepts[2].wikidata	https://www.wikidata.org/wiki/Q11190
concepts[2].display_name	Medicine
concepts[3].id	https://openalex.org/C57074206
concepts[3].level	3
concepts[3].score	0.5593368411064148
concepts[3].wikidata	https://www.wikidata.org/wiki/Q14197552
concepts[3].display_name	MAPK/ERK pathway
concepts[4].id	https://openalex.org/C46762472
concepts[4].level	2
concepts[4].score	0.5376781821250916
concepts[4].wikidata	https://www.wikidata.org/wiki/Q178648
concepts[4].display_name	Peripheral
concepts[5].id	https://openalex.org/C502942594
concepts[5].level	1
concepts[5].score	0.5059499144554138
concepts[5].wikidata	https://www.wikidata.org/wiki/Q3421914
concepts[5].display_name	Cancer research
concepts[6].id	https://openalex.org/C183713625
concepts[6].level	4
concepts[6].score	0.43003445863723755
concepts[6].wikidata	https://www.wikidata.org/wiki/Q5282002
concepts[6].display_name	Discovery and development of mTOR inhibitors
concepts[7].id	https://openalex.org/C126322002
concepts[7].level	1
concepts[7].score	0.2700560688972473
concepts[7].wikidata	https://www.wikidata.org/wiki/Q11180
concepts[7].display_name	Internal medicine
concepts[8].id	https://openalex.org/C62478195
concepts[8].level	2
concepts[8].score	0.2119947075843811
concepts[8].wikidata	https://www.wikidata.org/wiki/Q828130
concepts[8].display_name	Signal transduction
concepts[9].id	https://openalex.org/C86803240
concepts[9].level	0
concepts[9].score	0.15978571772575378
concepts[9].wikidata	https://www.wikidata.org/wiki/Q420
concepts[9].display_name	Biology
concepts[10].id	https://openalex.org/C95444343
concepts[10].level	1
concepts[10].score	0.08826836943626404
concepts[10].wikidata	https://www.wikidata.org/wiki/Q7141
concepts[10].display_name	Cell biology
keywords[0].id	https://openalex.org/keywords/pi3k/akt/mtor-pathway
keywords[0].score	0.8955535888671875
keywords[0].display_name	PI3K/AKT/mTOR pathway
keywords[1].id	https://openalex.org/keywords/protein-kinase-b
keywords[1].score	0.757625937461853
keywords[1].display_name	Protein kinase B
keywords[2].id	https://openalex.org/keywords/medicine
keywords[2].score	0.6529040932655334
keywords[2].display_name	Medicine
keywords[3].id	https://openalex.org/keywords/mapk/erk-pathway
keywords[3].score	0.5593368411064148
keywords[3].display_name	MAPK/ERK pathway
keywords[4].id	https://openalex.org/keywords/peripheral
keywords[4].score	0.5376781821250916
keywords[4].display_name	Peripheral
keywords[5].id	https://openalex.org/keywords/cancer-research
keywords[5].score	0.5059499144554138
keywords[5].display_name	Cancer research
keywords[6].id	https://openalex.org/keywords/discovery-and-development-of-mtor-inhibitors
keywords[6].score	0.43003445863723755
keywords[6].display_name	Discovery and development of mTOR inhibitors
keywords[7].id	https://openalex.org/keywords/internal-medicine
keywords[7].score	0.2700560688972473
keywords[7].display_name	Internal medicine
keywords[8].id	https://openalex.org/keywords/signal-transduction
keywords[8].score	0.2119947075843811
keywords[8].display_name	Signal transduction
keywords[9].id	https://openalex.org/keywords/biology
keywords[9].score	0.15978571772575378
keywords[9].display_name	Biology
keywords[10].id	https://openalex.org/keywords/cell-biology
keywords[10].score	0.08826836943626404
keywords[10].display_name	Cell biology
language	en
locations[0].id	doi:10.1158/1078-0432.22455300.v1
locations[0].is_oa	True
locations[0].source
locations[0].license	cc-by
locations[0].pdf_url	https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_Legend_from_Prognostic_Significance_of_AKT_mTOR_and_MAPK_Pathways_and_Antitumor_Effect_of_mTOR_Inhibitor_in_NF1-Related_and_Sporadic_Malignant_Peripheral_Nerve_Sheath_Tumors/22455300/1/files/39906432.pdf
locations[0].version	acceptedVersion
locations[0].raw_type	posted-content
locations[0].license_id	https://openalex.org/licenses/cc-by
locations[0].is_accepted	True
locations[0].is_published	False
locations[0].raw_source_name
locations[0].landing_page_url	https://doi.org/10.1158/1078-0432.22455300.v1
locations[1].id	pmh:oai:figshare.com:article/22455300
locations[1].is_oa	True
locations[1].source.id	https://openalex.org/S4306400572
locations[1].source.issn
locations[1].source.type	repository
locations[1].source.is_oa	False
locations[1].source.issn_l
locations[1].source.is_core	False
locations[1].source.is_in_doaj	False
locations[1].source.display_name	OPAL (Open@LaTrobe) (La Trobe University)
locations[1].source.host_organization	https://openalex.org/I196829312
locations[1].source.host_organization_name	La Trobe University
locations[1].source.host_organization_lineage	https://openalex.org/I196829312
locations[1].license	cc-by
locations[1].pdf_url
locations[1].version	submittedVersion
locations[1].raw_type	Text
locations[1].license_id	https://openalex.org/licenses/cc-by
locations[1].is_accepted	False
locations[1].is_published	False
locations[1].raw_source_name
locations[1].landing_page_url	https://figshare.com/articles/journal_contribution/Supplementary_Figure_Legend_from_Prognostic_Significance_of_AKT_mTOR_and_MAPK_Pathways_and_Antitumor_Effect_of_mTOR_Inhibitor_in_NF1-Related_and_Sporadic_Malignant_Peripheral_Nerve_Sheath_Tumors/22455300
indexed_in	crossref
authorships[0].author.id	https://openalex.org/A5048210816
authorships[0].author.orcid	https://orcid.org/0000-0002-7956-2190
authorships[0].author.display_name	Makoto Endo
authorships[0].author_position	first
authorships[0].raw_author_name	Makoto Endo
authorships[0].is_corresponding	False
authorships[1].author.id	https://openalex.org/A5053242194
authorships[1].author.orcid	https://orcid.org/0000-0001-9148-6445
authorships[1].author.display_name	Hidetaka Yamamoto
authorships[1].author_position	middle
authorships[1].raw_author_name	Hidetaka Yamamoto
authorships[1].is_corresponding	False
authorships[2].author.id	https://openalex.org/A5083645230
authorships[2].author.orcid	https://orcid.org/0000-0003-0042-3321
authorships[2].author.display_name	Nokitaka Setsu
authorships[2].author_position	middle
authorships[2].raw_author_name	Nokitaka Setsu
authorships[2].is_corresponding	False
authorships[3].author.id	https://openalex.org/A5012193751
authorships[3].author.orcid	https://orcid.org/0000-0002-2358-7452
authorships[3].author.display_name	Kenichi Kohashi
authorships[3].author_position	middle
authorships[3].raw_author_name	Kenichi Kohashi
authorships[3].is_corresponding	False
authorships[4].author.id	https://openalex.org/A5055175958
authorships[4].author.orcid	https://orcid.org/0000-0002-7974-1252
authorships[4].author.display_name	Yusuke Takahashi
authorships[4].author_position	middle
authorships[4].raw_author_name	Yusuke Takahashi
authorships[4].is_corresponding	False
authorships[5].author.id	https://openalex.org/A5044407567
authorships[5].author.orcid	https://orcid.org/0000-0003-0131-205X
authorships[5].author.display_name	Takeaki Ishii
authorships[5].author_position	middle
authorships[5].raw_author_name	Takeaki Ishii
authorships[5].is_corresponding	False
authorships[6].author.id	https://openalex.org/A5087496283
authorships[6].author.orcid
authorships[6].author.display_name	Kei-ichiro Iida
authorships[6].author_position	middle
authorships[6].raw_author_name	Kei-ichiro Iida
authorships[6].is_corresponding	False
authorships[7].author.id	https://openalex.org/A5087421653
authorships[7].author.orcid	https://orcid.org/0000-0002-0039-2855
authorships[7].author.display_name	Yoshihiro Matsumoto
authorships[7].author_position	middle
authorships[7].raw_author_name	Yoshihiro Matsumoto
authorships[7].is_corresponding	False
authorships[8].author.id	https://openalex.org/A5026217196
authorships[8].author.orcid	https://orcid.org/0000-0003-1641-0795
authorships[8].author.display_name	Michiyuki Hakozaki
authorships[8].author_position	middle
authorships[8].raw_author_name	Michiyuki Hakozaki
authorships[8].is_corresponding	False
authorships[9].author.id	https://openalex.org/A5102757867
authorships[9].author.orcid
authorships[9].author.display_name	Mikiko Aoki
authorships[9].author_position	middle
authorships[9].raw_author_name	Mikiko Aoki
authorships[9].is_corresponding	False
authorships[10].author.id	https://openalex.org/A5062214131
authorships[10].author.orcid	https://orcid.org/0000-0002-0153-6873
authorships[10].author.display_name	Hiroshi Iwasaki
authorships[10].author_position	middle
authorships[10].raw_author_name	Hiroshi Iwasaki
authorships[10].is_corresponding	False
authorships[11].author.id	https://openalex.org/A5069058165
authorships[11].author.orcid	https://orcid.org/0000-0003-0507-3332
authorships[11].author.display_name	Yoh Dobashi
authorships[11].author_position	middle
authorships[11].raw_author_name	Yoh Dobashi
authorships[11].is_corresponding	False
authorships[12].author.id	https://openalex.org/A5085641802
authorships[12].author.orcid	https://orcid.org/0000-0003-0478-4482
authorships[12].author.display_name	Kenichi Nishiyama
authorships[12].author_position	middle
authorships[12].raw_author_name	Kenichi Nishiyama
authorships[12].is_corresponding	False
authorships[13].author.id	https://openalex.org/A5011966088
authorships[13].author.orcid	https://orcid.org/0000-0003-0453-1733
authorships[13].author.display_name	Yukihide Iwamoto
authorships[13].author_position	middle
authorships[13].raw_author_name	Yukihide Iwamoto
authorships[13].is_corresponding	False
authorships[14].author.id	https://openalex.org/A5049884976
authorships[14].author.orcid	https://orcid.org/0000-0001-9636-1182
authorships[14].author.display_name	Yoshinao Oda
authorships[14].author_position	last
authorships[14].raw_author_name	Yoshinao Oda
authorships[14].is_corresponding	False
has_content.pdf	True
has_content.grobid_xml	True
is_paratext	False
open_access.is_oa	True
open_access.oa_url	https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_Legend_from_Prognostic_Significance_of_AKT_mTOR_and_MAPK_Pathways_and_Antitumor_Effect_of_mTOR_Inhibitor_in_NF1-Related_and_Sporadic_Malignant_Peripheral_Nerve_Sheath_Tumors/22455300/1/files/39906432.pdf
open_access.oa_status	gold
open_access.any_repository_has_fulltext	False
created_date	2025-10-10T00:00:00
display_name	Supplementary Figure Legend from Prognostic Significance of AKT/mTOR and MAPK Pathways and Antitumor Effect of mTOR Inhibitor in NF1-Related and Sporadic Malignant Peripheral Nerve Sheath Tumors
has_fulltext	False
is_retracted	False
updated_date	2025-11-06T03:46:38.306776
primary_topic.id	https://openalex.org/T11173
primary_topic.field.id	https://openalex.org/fields/27
primary_topic.field.display_name	Medicine
primary_topic.score	0.9994000196456909
primary_topic.domain.id	https://openalex.org/domains/4
primary_topic.domain.display_name	Health Sciences
primary_topic.subfield.id	https://openalex.org/subfields/2728
primary_topic.subfield.display_name	Neurology
primary_topic.display_name	Neurofibromatosis and Schwannoma Cases
related_works	https://openalex.org/W2024936926, https://openalex.org/W2095479222, https://openalex.org/W4361817057, https://openalex.org/W2145454786, https://openalex.org/W1561643266, https://openalex.org/W2901178839, https://openalex.org/W2618892274, https://openalex.org/W2035816919, https://openalex.org/W2958505263, https://openalex.org/W2890752806
cited_by_count	0
locations_count	2
best_oa_location.id	doi:10.1158/1078-0432.22455300.v1
best_oa_location.is_oa	True
best_oa_location.source
best_oa_location.license	cc-by
best_oa_location.pdf_url	https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_Legend_from_Prognostic_Significance_of_AKT_mTOR_and_MAPK_Pathways_and_Antitumor_Effect_of_mTOR_Inhibitor_in_NF1-Related_and_Sporadic_Malignant_Peripheral_Nerve_Sheath_Tumors/22455300/1/files/39906432.pdf
best_oa_location.version	acceptedVersion
best_oa_location.raw_type	posted-content
best_oa_location.license_id	https://openalex.org/licenses/cc-by
best_oa_location.is_accepted	True
best_oa_location.is_published	False
best_oa_location.raw_source_name
best_oa_location.landing_page_url	https://doi.org/10.1158/1078-0432.22455300.v1
primary_location.id	doi:10.1158/1078-0432.22455300.v1
primary_location.is_oa	True
primary_location.source
primary_location.license	cc-by
primary_location.pdf_url	https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_Legend_from_Prognostic_Significance_of_AKT_mTOR_and_MAPK_Pathways_and_Antitumor_Effect_of_mTOR_Inhibitor_in_NF1-Related_and_Sporadic_Malignant_Peripheral_Nerve_Sheath_Tumors/22455300/1/files/39906432.pdf
primary_location.version	acceptedVersion
primary_location.raw_type	posted-content
primary_location.license_id	https://openalex.org/licenses/cc-by
primary_location.is_accepted	True
primary_location.is_published	False
primary_location.raw_source_name
primary_location.landing_page_url	https://doi.org/10.1158/1078-0432.22455300.v1
publication_date	2023-03-31
publication_year	2023
referenced_works_count	0
abstract_inverted_index.-	2
abstract_inverted_index.file	1
abstract_inverted_index.<p>PDF	0
abstract_inverted_index.72K</p>	3
cited_by_percentile_year
countries_distinct_count	0
institutions_distinct_count	15
citation_normalized_percentile.value	0.08989608
citation_normalized_percentile.is_in_top_1_percent	False
citation_normalized_percentile.is_in_top_10_percent	False